Filing Details
- Accession Number:
- 0001209191-15-066176
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2015-08-14 20:36:08
- Reporting Period:
- 2015-08-12
- Filing Date:
- 2015-08-14
- Accepted Time:
- 2015-08-14 20:36:08
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1404644 | Aquinox Pharmaceuticals Inc | AQXP | Pharmaceutical Preparations (2834) | 000000000 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1600046 | Kamran Alam | C/O Aquinox Pharmaceuticals, Inc. 450 - 887 Great Northern Way Vancouver A1 V5T 4T5 | Cfo, Vice President Finance | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2015-08-12 | 8,246 | $5.76 | 8,246 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2015-08-12 | 20,833 | $5.76 | 29,079 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2015-08-12 | 29,079 | $18.67 | 0 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option (Right to Buy) | Disposition | 2015-08-12 | 8,246 | $0.00 | 8,246 | $5.76 |
| Common Stock | Stock Option (Right to Buy) | Disposition | 2015-08-12 | 20,833 | $0.00 | 20,833 | $5.76 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 2,170 | 2022-05-29 | No | 4 | M | Direct | |
| 0 | 2021-08-22 | No | 4 | M | Direct |
Footnotes
- The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $17.775 to $20.43. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price withinh the ranges set in this footnote.
- The shares subject to this option shall vest and become exercisable at a rate of twenty-five percent of the total number of shares underlying the options on the one-year anniversary of the vesting commencement date and 1/48th of the total number of shares underlying the options each monthly anniversary of the vesting commencement date thereafter for so long as the recipient of the option provides continuous service to the issuer, such that the total number of shares underlying the options shall be fully vested on the four-year anniversary of the vesting commencement date.
- Fully vested.
Billionaire Hedge Funds
